海外の治験の状況「1」での検索結果
1993件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 地域
- 登録日
Authorised
- A Phase I clinical trial to evaluate the safety and the activity of the oncolytic adenovirus VCN-01 in patients with refractory retinoblastoma
- Refractory Retinoblastoma MedDRA version: 20.0 Level: PT Classification code 10038916 Term: Retinoblastoma System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) ;Therapeutic area: Diseases [C] - Cancer [C04]
- Spain
- 2017-05-23
Authorised
- A phase I study of subcutaneous alemtuzumab in combination with oral fludarabine in previously untreated patients with chronic lymphocytic leukaemia. - FULLSCALE
- Chronic Lymphocytic Leukaemia (CLL)
- United Kingdom
- 2006-03-20
Authorised
- Effect of nasal GLP-1 versus placebo on fasting state and postprandial hyperglycaemia in type 2 diabetes. A single centre, prospective, placebo controlled clinical trial evaluating efficacy and safety of nasal GLP-1 versus placebo in type 2 diabetes.
- Diabetes Mellitus type 2
- Denmark
- 2006-11-01
Authorised
- open, non comparative, prospectic, phase IV clinical study to evaluate the activity and tolerance of Cinacalcet-HCl (drug name Mimpara) in patients affected by MEN1-associated primary hyperparathyroidism - ipermen
- Primary hyperparathyroidism in patients with MEN1 br>MedDRA version: 12.0 Level: LLT Classification code 10020707 Term: Hyperparathyroidism primary
- Italy
- 2009-06-18
Authorised
- Effect of Interleukin-1 receptor antagonist on insulin sensitivity in subjects with type 1 diabetes mellitus. - Effect of IL-1RA on insulin sensitivity
- diabetes mellitus MedDRA version: 12.1 Level: LLT Classification code 10012601 Term: Diabetes mellitus
- Netherlands
- 2010-11-08
Authorised
- A Phase 1 Study to Evaluate Multiple Doses of golimumab in Participants At-Risk for Developing Type-1 Diabetes.
- A Phase 1b Study to Evaluate SIMPONI® (golimumab) Therapy in Children, Adolescents and Young Adults with Pre-Symptomatic Type 1 Diabetes MedDRA version: 20.0 Level: PT Classification code 10067584 Term: Type 1 diabetes mellitus System Organ Class: 10027433 - Metabolism and nutrition disorders ;Therapeutic area: Body processes [G] - Immune system processes [G12]
- Finland, Sweden
- 2017-06-08
Authorised
- A Phase 1 Study to Evaluate Multiple Doses of golimumab in Participants At-Risk for Developing Type-1 Diabetes.
- A Phase 1b Study to Evaluate SIMPONI® (golimumab) Therapy in Children, Adolescents and Young Adults with Pre-Symptomatic Type 1 Diabetes MedDRA version: 20.0 Level: PT Classification code 10067584 Term: Type 1 diabetes mellitus System Organ Class: 10027433 - Metabolism and nutrition disorders ;Therapeutic area: Body processes [G] - Immune system processes [G12]
- Finland, Sweden
- 2017-04-26
Authorised
- Hepatitis C Study with GT 1 2 and 3.
- Chronic Hepatitis C infection MedDRA version: 20.0 Level: LLT Classification code 10076789 Term: Chronic hepatitis C genotype 2 System Organ Class: 100000004862 MedDRA version: 20.0 Level: LLT Classification code 10076831 Term: Chronic hepatitis C genotype 3 System Organ Class: 100000004862 MedDRA version: 20.0 Level: LLT Classification code 10076786 Term: Chronic hepatitis C genotype 1 System Organ Class: 100000004862 ;Therapeutic area: Diseases [C] - Virus Diseases [C02]
- Georgia, Mauritius, Moldova, Republic of, New Zealand, Romania, United Kingdom
- 2016-11-11
Authorised
- A Phase 1/2, Open-Label, Dose-Escalation/Dose-Expansion, Safety and Tolerability Study of INCB059872 in Subjects With Advanced Malignancies
- Potential subjects include those with advanced or metastatic malignancies who are ineligible for all therapeutic options that are standard of care or known to confer clinical benefit, or who refuse these treatments. MedDRA version: 20.0 Level: LLT Classification code 10048683 Term: Advanced cancer System Organ Class: 100000004864 ;Therapeutic area: Diseases [C] - Cancer [C04]
- Belgium, Netherlands, United States
- 2017-08-09
Authorised
- Near-infrared Fluorescence-Enhanced Identification of the Ureters using ZW800-1
- The trial is conducted in patients where ZW800-1 is used to visualize ureters during surgery.;Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Investigative Techniques [E05]
- Netherlands
- 2017-08-03
